
Client Services Executive
This campaign demonstrates the success of targeting prospects on a global scale within the broader Pharmaceutical sectors. Our ability to identify the correct type of companies based on niche target offerings is demonstrated with lead rates ranging from 3-6% over a period of a year and an overall average lead rate of 3.77% (£52.98 – cost per lead). I particularly value the knowledge gained in terms of how stem cell technologies can contribute to human health and welfare
Reprocell
Company Profile
Location: USA
Product/Service: REPROCELL was established with the goal of contributing to people’s health and welfare through the development of stem cell technologies.
Deal Cycle: 3 – 6 months
Target Profile
Location: USA & Europe
Company Size: Any, but initial focus on larger
Role/Function: Owners & C-suite, or senior figures in R&D, projects and a range of specific scientific areas
Company Description
- Offer Research Contracts to Pharma companies who would like to test IBD drugs in Reprocell labs. Contract Research Service Offering under the BIOPTA brand
- REPROCELL’s stem cell services team is a specialized research group with training in stem cell biology received in leading stem cell labs from around the world
- They will provide exactly the cells needed for investigations, freeing up time and resources to focus on the research
Objectives
- Focus is to start dialogue with ideally large Pharma companies in the US and EU, initially inviting them for a call around the two core offerings: IBD and Stem Cell IPC